26.02.2013 Views

Bulletin 2011/51 - European Patent Office

Bulletin 2011/51 - European Patent Office

Bulletin 2011/51 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(1)<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) IL 2010/000117 10.02.2010<br />

(87) WO 2010/092571 2010/33 19.08.2010<br />

(88) 07.10.2010<br />

(30) 11.02.2009 US 1<strong>51</strong>527 P<br />

(54) • KURZE PEPTIDE AUS BETA-DEFENSIN<br />

• SHORT BETA-DEFENSIN-DERIVED PEP-<br />

TIDES<br />

• PEPTIDES COURTS DÉRIVÉS DE BÊTA-<br />

DÉFENSINE<br />

(71) Yeda Research and Development Co. Ltd., At<br />

the Weizmann Institute of Science P.O. Box<br />

95, 76100 Rehovot, IL<br />

(72) LAPIDOT, Tsvee, 74046 Ness Ziona, IL<br />

KALINKOVICH, Alexander, 76217 Rehovot,<br />

IL<br />

FRIDKIN, Matityahu, 76284 Rehovot, IL<br />

(74) Becker Kurig Straus, <strong>Patent</strong>anwälte Bavariastrasse<br />

7, 80336 München, DE<br />

(<strong>51</strong>) A61K 38/17 (11) 2 396 024 A1*<br />

A61P 35/00 G01N 33/574<br />

(25) En (26) En<br />

(21) 10741487.2 (22) 11.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) SE 2010/050165 11.02.2010<br />

(87) WO 2010/093324 2010/33 19.08.2010<br />

(30) 11.02.2009 SE 0900170<br />

(54) • VERWENDUNG VON ANTISEKRETORI-<br />

SCHEN FAKTOREN (AF) FÜR OPTMIERTE<br />

ZELLULÄRE AUFNAHME<br />

• USE OF ANTISECRETORY FACTORS (AF)<br />

FOR OPTIMIZING CELLULAR UPTAKE<br />

• UTILISATION DE FACTEURS ANTISÉCRÉ-<br />

TOIRES (AF) POUR OPTIMISATION DE<br />

L'ABSORPTION CELLULAIRE<br />

(71) Lantmännen AS-Faktor AB, Box 30192,<br />

10425 Stockholm, SE<br />

(72) JENNISCHE, Eva, S-411 28 Göteborg, SE<br />

LANGE, Stefan, S-411 28 Göteborg, SE<br />

HANSSON, Hans-Arne, S-436 58 Hovås, SE<br />

(74) VALEA AB, Box 7086, 103 87 Stockholm, SE<br />

A61K 38/17 → (<strong>51</strong>) A61K 31/4188<br />

A61K 38/17 → (<strong>51</strong>) C07K 14/465<br />

(<strong>51</strong>) A61K 38/18 (11) 2 396 025 A2*<br />

A61K 9/00<br />

(25) En (26) En<br />

(21) 10705489.2 (22) 12.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/024106 12.02.2010<br />

(87) WO 2010/093925 2010/33 19.08.2010<br />

(88) 28.10.2010<br />

(30) 12.02.2009 US 1<strong>51</strong>909 P<br />

(54) • PERIPHERE VERABREICHUNG VON PRO-<br />

TEINEN EINSCHLIESSLICH MITGLIEDER<br />

DER TGF-BETA-SUPERFAMILIE ZUR SYS-<br />

TEMISCHEN BEHANDLUNG VON STÖ-<br />

RUNGEN UND ERKRANKUNGEN<br />

• PERIPHERAL ADMINISTRATION OF PRO-<br />

TEINS INCLUDING TGF-BETA SUPERFAM-<br />

ILY MEMBERS FOR SYSTEMIC<br />

TREATMENT OF DISORDERS AND DIS-<br />

EASE<br />

• ADMINISTRATION PÉRIPHÉRIQUE DE<br />

PROTEINES NOTAMMENT DES MEMBRES<br />

DE LA SUPERFAMILLE DU TGF-BETA<br />

POUR LE TRAITEMENT SYSTÉMIQUE DE<br />

DESORDRES OU DE MALADIES<br />

(71) Stryker Corporation, 2825 Airview Boulevard,<br />

Kalamazoo, MI 49002, US<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(72) GOAD, Mary Elizabeth, Pecquet, Andover MA<br />

01810, US<br />

HASKELL, Melissa, M., Uxbridge MA 01569,<br />

US<br />

SCHRIER, Denis, Hopkinton MA 01748, US<br />

WOOD, Susan, A., Dedham MA 02026, US<br />

(74) Sharples, Andrew John, et al, EIP Fairfax<br />

House 15 Fulwood Place, London WC1V<br />

6HU, GB<br />

(<strong>51</strong>) A61K 38/18 (11) 2 396 026 A2*<br />

A61K 9/00<br />

(25) En (26) En<br />

(21) 10705490.0 (22) 12.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/024124 12.02.2010<br />

(87) WO 2010/093941 2010/33 19.08.2010<br />

(88) 28.10.2010<br />

(30) 12.02.2009 US 1<strong>51</strong>902 P<br />

(54) • ZUSAMMENSETZUNGEN UND VERFAH-<br />

REN FÜR DIE MINIMAL INVASIVE SYS-<br />

TEMISCHE ABGABE VON PROTEINEN<br />

EINSCHLIESSLICH MITGLIEDER DER TGF-<br />

SUPERFAMILIE<br />

• COMPOSITIONS AND METHODS FOR<br />

MINIMALLY-INVASIVE SYSTEMIC DELIV-<br />

ERY OF PROTEINS INCLUDING TGF-<br />

SUPERFAMILY MEMBERS<br />

• COMPOSITIONS ET PROCEDES POUR<br />

L'ADMINISTRATION SYSTEMIQUE DE<br />

PROTEINES A INVASION MINIMALE<br />

INCLUANT DES MEMBRES DE LA<br />

SUPERFAMILLE DU TGF-BETA<br />

(71) Stryker Corporation, 2825 Airview Boulevard,<br />

Kalamazoo, MI 49002, US<br />

(72) PECQUET GOAD, Mary, Elizabeth, Andover<br />

MA 01810, US<br />

SCHRIER, Denis, Hopkinton MA 01748, US<br />

PIERCE, Allen, Richard, Acton MA 01720, US<br />

(74) Sharples, Andrew John, et al, EIP Fairfax<br />

House 15 Fulwood Place, London WC1V<br />

6HU, GB<br />

(<strong>51</strong>) A61K 38/18 (11) 2 396 027 A2*<br />

A61P 25/28 A61P 39/04<br />

A61K 31/4412<br />

(25) En (26) En<br />

(21) 10709060.7 (22) 12.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) IB 2010/000426 12.02.2010<br />

(87) WO 2010/092485 2010/33 19.08.2010<br />

(88) 25.11.2010<br />

(30) 12.02.2009 PCT/IB2009/000481<br />

(54) • KOMBINATIONSTHERAPIE FÜR MULTIPLE<br />

SKLEROSE<br />

• COMBINED TREATMENT OF MULTIPLE<br />

SCLEROSIS<br />

• TRAITEMENT COMBINE DE LA SCLEROSE<br />

EN PLAQUES<br />

(71) Assistance Publique - Hopitaux De Paris, 228<br />

rue du Faubourg Saint Martin, 75010 Paris,<br />

FR<br />

(72) CREANGE, Alain, F-91230 Montgeron, FR<br />

GALACTEROS, Frédéric, F-94440 Santeny,<br />

FR<br />

LEFAUCHEUR, Jean-Pascal, F-75012 Paris,<br />

FR<br />

(74) Marcadé, Véronique, et al, Cabinet Ores 36,<br />

rue de St Pétersbourg, 75008 Paris, FR<br />

(<strong>51</strong>) A61K 38/21 (11) 2 396 028 A2*<br />

(25) En (26) En<br />

(21) 10705482.7 (22) 12.02.2010<br />

43<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>51</strong>/<strong>2011</strong>) 21.12.<strong>2011</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/023978 12.02.2010<br />

(87) WO 2010/093843 2010/33 19.08.2010<br />

(88) 07.10.2010<br />

(30) 12.02.2009 US 152120 P<br />

22.04.2009 US 171654 P<br />

30.10.2009 US 256686 P<br />

(54) • HCV-KOMBINATIONSTHERAPIEN MIT<br />

PEGYLIERTEM INTERFERON, RIBAVIRIN<br />

UND TELAPREVIR<br />

• HCV COMBINATION THERAPIES COM-<br />

PRISING PEGYLATED INTERFERON,<br />

RIBAVIRIN AND TELAPREVIR<br />

• POLYTHÉRAPIE CONTRE LE HCV COM-<br />

PRENANT DE L'INTERFÉRON PÉGYLÉ, DE<br />

LA RIBAVIRINE ET DE LA TELAPREVIR<br />

(71) Vertex Pharmaceuticals Incorporated, 130<br />

Waverly Street, Cambridge, MA 02139-4242,<br />

US<br />

Janssen Pharmaceutica, N.V., Turnhoutseweg<br />

30, 2340 Beerse, BE<br />

(72) MCNAIR, Lindsay, Allston Massachusetts<br />

02134, US<br />

KAUFFMAN, Robert S., Chestnut Hill Massachusetts<br />

02467, US<br />

ALAM, John J., Cambridge Massachusetts<br />

02138, US<br />

PICCHIO, Gaston Rafael, Flemington, NJ<br />

08822, US<br />

POLO, Ramon, Basking Ridge, NJ 07920, US<br />

BEUMONT, Maria Gloria, 92787 Issy Les<br />

Moulineaux, FR<br />

(74) Burrichter, Arwed Andreas, COHAUSZ &<br />

FLORACK <strong>Patent</strong>- und Rechtsanwälte Partnerschaftsgesellschaft<br />

Bleichstrasse 14,<br />

40211 Düsseldorf, DE<br />

A61K 39/00 → (<strong>51</strong>) A61K 31/216<br />

A61K 39/00 → (<strong>51</strong>) A61P 35/00<br />

(<strong>51</strong>) A61K 39/02 (11) 2 396 029 A1*<br />

A61K 39/108<br />

(25) En (26) En<br />

(21) 10741713.1 (22) 11.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/023873 11.02.2010<br />

(87) WO 2010/093776 2010/33 19.08.2010<br />

(30) 11.02.2009 US 1<strong>51</strong>772 P<br />

(54) • ANTIBIOTISCHE THERAPIE ZUR REDU-<br />

ZIERUNG DER WAHRSCHEINLICHKEIT<br />

DER ENTWICKLUNG DES POSTINFEKTIÖ-<br />

SEN REIZDARMSYNDROMS<br />

• ANTIBIOTIC THERAPY TO REDUCE THE<br />

LIKELIHOOD OF DEVELOPING POST-<br />

INFECTIOUS IRRITABLE BOWEL SYN-<br />

DROME<br />

• THÉRAPIE ANTIBIOTIQUE DESTINÉE À<br />

RÉDUIRE LE RISQUE DE DÉVELOPPER UN<br />

SYNDROME DU CÔLON IRRITABLE POST-<br />

INFECTIEUX<br />

(71) Cedars-Sinai Medical Center, 8700 Beverly<br />

Boulevard, Los Angeles, California 90048,<br />

US<br />

(72) PIMENTEL, Mark, Los Angeles California<br />

90034, US<br />

CHANG, Christopher, Los Angeles California<br />

90034, US<br />

(74) Harrison Goddard Foote, 4th Floor, Merchant<br />

Exchange 17-19 Whitworth Street West,<br />

Manchester M1 5WG, GB<br />

A61K 39/108 → (<strong>51</strong>) A61K 39/02<br />

(<strong>51</strong>) A61K 39/145 (11) 2 396 030 A1*<br />

(25) En (26) En

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!